Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-02-28
1999-08-17
Moezie, Minna
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
059394269
ABSTRACT:
Methods for treating urinary incontinence comprising administering a therapeutically effective amount of descarboethoxyloratadine, or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 3940485 (1976-02-01), Levinson et al.
patent: 4008796 (1977-02-01), Aylon
patent: 4282233 (1981-08-01), Vilani
patent: 4659716 (1987-04-01), Villani et al.
patent: 4777170 (1988-10-01), Heinrich
patent: 5595997 (1997-01-01), Aberg et al.
Andersen and Feingold, 1995, "Adverse Drug Interactions Clinically Important for the Dermatologist", Arch. Dermatol. 131:468-473.
Berge, S. et al., 1977, "Pharmaceutical Salts", J. of Pharmaceutical Sciences 66:1-19.
Brandes, L. et al., 1992, "Stimulation of Malignant Growth in Rodents by Antidepressant Drugs at Clinically Relevant Doses", Cancer Research 52:3796-3800.
Brandes, L. et al., 1994, "Enhanced Cancer Growth in Mice Administered Daily Human-Equivalent Doses of Some H.sub.1 -Antihistamines: Predictive In Vitro Correlates", J. Nat'l. Cancer Institute 86:770-775.
Carmeliet, 1992, "Voltage- and Time-Dependent Block of the Delayed K.sup.+ Current in Cardiac Myocytes by Dofetilide", J. Pharmocol. Exper. Ther. 262:809-817.
Cheung, B.S.K., et al., 1992, "Investigation of Anti-Motion Sickness Drugs in the Squirrel Monkey", J. Clin. Pharmacol. 32:163-175.
Clissold et al., 1989, "Loratadine: A Preliminary Reivew of its Pharmacodynamic Properties and Therapeutic Efficacy", Drugs 37:42-57.
Cohen, B. et al., 1972, "Meclizine and Placebo in Treating Vertigo of Vestibular Origin", Arch. Neurol. 27:129-137.
Cooke, R.D., 1983, "Glycopyrrolate in Bladder Dysfunction", S. Afr. Med. J. 63:3.
Craft, T., 1986, "Torsade de Pointes after Astemizole Overdose", British Medical Journal 292:660.
Dorje, F. et al., 1991, "Antagonist Binding Profiles of Five Cloned Human Muscarinic Receptor Subtypes", J. Pharmacology and Experimental Therapeutics 256:727-733.
Ebert, W., 1977, "Soft Elastic Gelatin Capsules: A Unique Dosage Form", Pharmaceutical Technology 1:44-50.
Goodman and Gilman's, 1996, The Pharmacological Basis of Therapeutics, 9th Ed. pp. 148, 588-592.
Herzog, A.R. et al., 1989, "Urinary Incontinence: Medical and Psychosocial Aspects", Annu. Rev. Gerontol. Geriatr. 9:74-119.
Hilbert, J. et al., 1987, "Pharmacokinetics and Dose Proportionality of Loratadine", J. Clin. Pharmacol. 27:694-698.
Knowles, S., 1992, "Astemizole and Terfenadine-Induced Cardiovascular Effects", Canadian J. Hospital Pharmacy 45:33-34.
Kohl and MacDonald, 1991, "New Pharmacologic Approaches to the Prevention of Space/Motion Sickness", J. Clin. Pharmacol. 31:934-946.
Kubo, N. et al., 1987, "Antimuscarinic Effects of Antihistamines: Quantitative Evaluation by Receptor-Binding Assay", Japan J. Pharmacol. 43:277-282.
Lathers, C. et al., 1989, "Pharmacology in Space", TiPS, 10:243-250.
Levin and Wein, 1982, "Direct Measurement of the Anticholinergic Activity of a Series of Pharmacological Compounds on the Canine and Rabbit Urinary Bladder", J. Urology 128:396-398.
Lunde, I., 1990, "Antihistamines", Side Effects of Drugs 14:135-138.
Massad, C. et al., 1992, "The Pharmokinetics of Intravesical and Oral Oxybutynin Chloride", J. Urology 148:595-597.
McCue, J., 1996, "Safety of Antihistamines in the Treatment of Allergic Rhinitis in Elderly Patients", Arch. Fam. Med. 5:464-468.
Mirakhur and Dundee, 1983, "Glycopyrrolate: Pharmacology and Clinical Use", Anaesthesia 38:1195-1204.
Mitchelson, F., 1992, "Pharmacological Agents Affecting Emesis", Drugs 43:443-463.
Muskat, Y. et al., 1996, "The Use of Scopolamine in the Treatment of Detrusor Instability", J. Urology 156:1989-1990.
Neiemans, F.A., 1988, "Antiallergic and Antitussive Drugs", Side Effects of Drugs 12:144-147.
Peggs and Shimp, 1995, "Antihistamines: The Old and The New", American Family Physician 52:593-600.
Quercia and Broisman, 1993, "Focus on Loratadine: A New Second-Generation Nonsedating H.sub.1 -Receptor Antagonist", Hosp. Formul. 28:137-153.
Resnick, N., 1995, "Urinary Incontinence", The Lancet 346:94-99.
Roman and Danzig, 1993, "Loratadine", Clinical Reviews in Allergy 11:89-110.
Simons, F.E.R. et al., 1988, "Astemizole-Induced Torsade de Pointes", The Lancet 2:624.
Simons, F.E.R., 1994, "H.sub.1 -Receptor Antagonists", Drug Safety 10:350-380.
Wein, A., 1995, "Pharmacology of Incontinence", Urol. Clin. N. Am. 22:557-577.
Wood, C., 1979, "Antimotion Sickness and Antiemetic Drugs", Drugs 17:471-479.
Yarker, Y. et al., 1995, "Oxybutynin", Drugs & Aging 6:243-262.
M.N.G. Dukes et al., "Side Effects of Drugs Annual 12," Elsevier Science Publishers B.V.: 142-143 (1988).
Petrin, A., 1974, "Motion Sickness and its Treatment", Schweiz. Med. 63:79-81.
Wood, C.D. et al., 1987, "Mechanisms of Antimotion Sickness Drugs", Aviation, Space, and Envir. Med. 58 (9, Suppl.) pp. A262-A265.
Moezie Minna
Sepracor Inc.
LandOfFree
Methods for treating urinary incontinence using descarboethoxylo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating urinary incontinence using descarboethoxylo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating urinary incontinence using descarboethoxylo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-315014